It is hard to believe that 17 years have passed since Zoltan Z. Nagy, MD, PhD, performed the first femtosecond laser-assisted cataract surgery procedure worldwide.At the time, the main advantages of the procedure over conventional cataract surgery incl…
Author: Healio ophthalmology
Experts debate if atropine should be standard of care for myopia control
SEVILLE, Spain — Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.Myopia has become a global epidemic and is associated with complications such as…
Leaders will discuss business of ophthalmology during SightLine at ASCRS
Things will be a little different ahead of this year’s American Society of Cataract and Refractive Surgery meeting in Los Angeles as ASCRS debuts SightLine, a new single-day meeting.The April 24 meeting will bring surgeons together with practice admini…
Tenpoint submits new drug application for presbyopia combination therapy
Editor’s note: This is a developing news story. Please check back soon for updates.Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, according to a press release.Brimochol PF (carb…
VIDEO: COPHy co-chairs highlight hot topics from the meeting
SEVILLE, Spain — In this Healio Video Perspective, Anat Loewenstein, MD, MHA, and Baruch D. Kuppermann, MD, PhD, highlight topics discussed at the Congress on Controversies in Ophthalmology.“We’ve had a lot of interesting debates with great participati…
Cell-based subretinal implant may partially restore vision in geographic atrophy
SEVILLE, Spain — A cell-based subretinal implant shows promise in the treatment of geographic atrophy, achieving the unprecedented milestone of partially restoring vision.During his keynote lecture at the Congress on Controversies in Ophthalmology, Mar…
Man presents with 2-year history of binocular vertical diplopia
A 64-year-old white man was seen in the neuro-ophthalmology clinic for 2 years of binocular vertical diplopia more noticeable at distance.He had no decrease in vision, eye pain, flashes, floaters or ptosis. There was no recent history of trauma. System…
Debulking vitreous can make phaco safe in crowded eyes
Small, crowded eyes tend to make phacoemulsification challenging.Short axial length coupled with a crowded anterior chamber angle and increased vitreous pressure is a surgeon’s nightmare. Performing a capsulorrhexis in such eyes is a difficult proposit…
Cutting back on steroid drops after cataract surgery: What are the alternatives?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.One of the most common concerns after cataract surger…
Trauma-related conditions may be notable risk factor for late in-the-bag IOL dislocation
Late in-the-bag IOL dislocation has a number of risk factors, including trauma-related conditions, as well as protective factors, according to a study published in the Journal of Cataract & Refractive Surgery.“Although numerous risk factors for ITB dis…
Senate confirms Oz to lead CMS
The Senate confirmed Mehmet Oz, MD, MBA, as the next CMS administrator in a vote Thursday.Known colloquially as “Dr. Oz,” the surgeon, professor emeritus of cardiothoracic surgery at Columbia University and former television personality was confirmed i…
Weigh whether surgical intervention for vitreous opacities is warranted
As discussed in last issue’s Lindstrom’s Perspective, some ocular media opacities warrant surgical intervention and some do not.To me an opacity in the vitreous is no different from an opacity in the cornea, natural lens or posterior capsule. If the op…
Manage patient expectations to treat vitreous opacities
As we move forward into a new era of ophthalmology, with increased options to address vision issues, patient expectations are more important than ever.Patients who might be affected by vitreous opacities after cataract surgery are not going to be satis…
FDA does not approve resubmitted new drug application for reproxalap
The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of signs and symptoms of dry eye disease, according to a press release from Aldeyra Therapeutics.The FDA cited a lack of efficacy in…
Alcon introduces Clareon PanOptix Pro IOL
Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients with cataracts, according to a press release.The IOL is designed to provide patients with more uninterrupted light distributio…
Vitrectomy offers relief for vitreous opacities
Eric D. Donnenfeld, MD, said that some ophthalmologists downplay the effects of more serious floaters, which he called vitreous opacifications.In this second of a two-part series on vitreous floaters, Healio | OSN spoke with another group of clinicians…
Age, clinical activity may affect glucocorticoid therapy response for thyroid eye disease
Older adults and those with a worse thyroid eye disease clinical activity score at baseline were less likely to respond to glucocorticoid therapy, according to findings published in Thyroid.“The leading position of intravenous glucocorticoids as the fi…
A surgeon’s guide to undergoing refractive lens exchange
For nearly 30 years, I have confidently helped patients navigate the IOL selection process for both cataract surgery and refractive lens exchange.Like all surgeons, I consider several factors, including patients’ ocular anatomy, age, occupation, lifest…
Posterior capsule rupture most likely to occur during phaco stage of cataract surgery
ATHENS, Greece — Posterior capsule rupture is most likely to occur at the stage of sculpting or quadrant removal, is affected by the presence of anterior capsule tears and influences where to implant an IOL, according to a presenter.“Although we have q…
Opthea discontinues development of sozinibercept in wet AMD
Editor’s note: This is a developing news story. Please check back soon for updates.Opthea has discontinued development of sozinibercept in wet age-related macular degeneration, according to a press release.After the March 24 release of negative results…